Skip to main content

Advertisement

SpringerLink
Log in

FokI polymorphism in vitamin D receptor gene and risk of breast cancer among Caucasian women

  • Research Article
  • Published:
Tumor Biology

Abstract

Vitamin D plays a central role in cellular proliferation, apoptosis induction, and tumor growth suppression. The vitamin D receptor (VDR) is a crucial mediator for the cellular effects of vitamin D. A series of epidemiological studies have examined the association between the VDR FokI polymorphism and breast cancer risk, but the findings remain inconclusive. Fifteen eligible case–control studies involving 15,681 cancer cases and 20,632 control subjects were identified through searching PubMed, Embase, and Web of Science. Odds ratios (ORs) and 95 % confidence intervals (CIs) were used to assess the association. Heterogeneity across studies was examined with the chi-square-based Q test and the I 2 index. Begg’s and Egger’s test were also performed to determine publication bias. All statistical data were analyzed by STATA software. The combined estimates did not show significant risks correlated with the FokI polymorphism. However, we found an increased risk in the subgroup analysis by source of control (OR = 1.11, 95 % CI = 1.01–1.22; heterogeneity test: P = 0.116, I 2 = 0.0 % for ff vs FF; OR = 1.10, 95 % CI = 1.01–1.21; heterogeneity test: P = 0.832, I 2 = 0.0 % for ff vs Ff + FF). This meta-analysis suggests that the presence of FokI polymorphism may contribute to the risk of breast cancer in Caucasians.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Uitterlinden AG et al. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338(2):143–56.

    Article  CAS  PubMed  Google Scholar 

  2. Bertone-Johnson ER et al. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2005;14(8):1991–7.

    Article  CAS  PubMed  Google Scholar 

  3. Crew KD et al. Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila). 2009;2(6):598–604.

    Article  CAS  Google Scholar 

  4. Janowsky EC et al. Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk. Public Health Nutr. 1999;2(3):283–91.

    Article  CAS  PubMed  Google Scholar 

  5. Lowe LC et al. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer. 2005;41(8):1164–9.

    Article  CAS  PubMed  Google Scholar 

  6. Jensen SS et al. Inhibitory effects of 1alpha, 25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery. Mol Endocrinol. 2001;15(8):1370–80.

    CAS  PubMed  Google Scholar 

  7. Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007;7(9):684–700.

    Article  CAS  PubMed  Google Scholar 

  8. Colston KW, Berger U, Coombes RC. Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet. 1989;1(8631):188–91.

    Article  CAS  PubMed  Google Scholar 

  9. Hansen CM et al. Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis. Front Biosci. 2001;6:D820–48.

    Article  CAS  PubMed  Google Scholar 

  10. Guyton KZ, Kensler TW, Posner GH. Vitamin D and vitamin D analogs as cancer chemopreventive agents. Nutr Rev. 2003;61(7):227–38.

    Article  PubMed  Google Scholar 

  11. Polly P et al. Identification of a vitamin D3 response element in the fibronectin gene that is bound by a vitamin D3 receptor homodimer. J Cell Biochem. 1996;60(3):322–33.

    Article  CAS  PubMed  Google Scholar 

  12. Liu M et al. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 1996;10(2):142–53.

    Article  CAS  PubMed  Google Scholar 

  13. Polly P et al. 1 alpha,25-dihydroxyvitamin D3 receptor as a mediator of transrepression of retinoid signaling. J Cell Biochem. 1997;67(3):287–96.

    Article  CAS  PubMed  Google Scholar 

  14. Berger U et al. Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues. J Clin Endocrinol Metab. 1988;67(3):607–13.

    Article  CAS  PubMed  Google Scholar 

  15. Cui Y, Rohan TE. Vitamin D, calcium, and breast cancer risk: a review. Cancer Epidemiol Biomarkers Prev. 2006;15(8):1427–37.

    Article  CAS  PubMed  Google Scholar 

  16. Barroso E et al. Genetic analysis of the vitamin D receptor gene in two epithelial cancers: melanoma and breast cancer case-control studies. BMC Cancer. 2008;8:385.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Chen WY et al. Associations between polymorphisms in the vitamin D receptor and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2005;14(10):2335–9.

    Article  CAS  PubMed  Google Scholar 

  18. Gapska P et al. Vitamin D receptor variants and breast cancer risk in the polish population. Breast Cancer Res Treat. 2009;115(3):629–33.

    Article  CAS  PubMed  Google Scholar 

  19. Sinotte M et al. Vitamin D receptor polymorphisms (FokI, BsmI) and breast cancer risk: association replication in two case-control studies within French Canadian population. Endocr Relat Cancer. 2008;15(4):975–83.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Anderson LN et al. Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in Ontario. Cancer Epidemiol Biomarkers Prev. 2011;20(8):1708–17.

    Article  CAS  PubMed  Google Scholar 

  21. Curran JE et al. Association of A vitamin D receptor polymorphism with sporadic breast cancer development. Int J Cancer. 1999;83(6):723–6.

    Article  CAS  PubMed  Google Scholar 

  22. Guy M et al. Vitamin D receptor gene polymorphisms and breast cancer risk. Clin Cancer Res. 2004;10(16):5472–81.

    Article  CAS  PubMed  Google Scholar 

  23. John EM et al. Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. Am J Epidemiol. 2007;166(12):1409–19.

    Article  PubMed  Google Scholar 

  24. Higgins JP et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–48.

    CAS  PubMed  Google Scholar 

  26. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.

    Article  CAS  PubMed  Google Scholar 

  27. Egger M et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. McCullough ML et al. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res. 2007;9(1):R9.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Abbas S et al. Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Cancer Res. 2008;10(2):R31.

    Article  PubMed Central  PubMed  Google Scholar 

  30. McKay JD et al. Vitamin D receptor polymorphisms and breast cancer risk: results from the National cancer institute breast and prostate cancer cohort consortium. Cancer Epidemiol Biomarkers Prev. 2009;18(1):297–305.

    Article  CAS  PubMed  Google Scholar 

  31. Engel LS et al. Vitamin D receptor gene haplotypes and polymorphisms and risk of breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev. 2012;21(10):1856–67.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Rollison DE et al. Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S.A. Breast Cancer Res Treat. 2012;132(2):683–91.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  33. Fuhrman BJ et al. Sunlight, polymorphisms of vitamin D-related genes and risk of breast cancer. Anticancer Res. 2013;33(2):543–51.

    CAS  PubMed Central  PubMed  Google Scholar 

  34. Mishra DK et al. Vitamin D receptor gene polymorphisms and prognosis of breast cancer among African-American and Hispanic women. PLoS One. 2013;8(3):e57967.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Shahbazi S et al. BsmI but not FokI polymorphism of VDR gene is contributed in breast cancer. Med Oncol. 2013;30(1):393.

    Article  PubMed  Google Scholar 

  36. Banerjee P, Chatterjee M. Antiproliferative role of vitamin D and its analogs—a brief overview. Mol Cell Biochem. 2003;253(1–2):247–54.

    Article  CAS  PubMed  Google Scholar 

  37. Welsh J. Vitamin D and breast cancer: insights from animal models. Am J Clin Nutr. 2004;80(6 Suppl):1721S–4S.

    CAS  PubMed  Google Scholar 

  38. Bouillon R et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008;29(6):726–76.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  39. Arai H et al. A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res. 1997;12(6):915–21.

    Article  CAS  PubMed  Google Scholar 

  40. Raimondi S et al. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis. 2009;30(7):1170–80.

    Article  CAS  PubMed  Google Scholar 

  41. Tang C et al. Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat. 2009;117(2):391–9.

    Article  CAS  PubMed  Google Scholar 

  42. Economopoulos KP, Sergentanis TN. Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: a meta-analysis. Breast Cancer Res Treat. 2010;120(1):211–6.

    Article  PubMed  Google Scholar 

  43. Thakkinstian A et al. A method for meta-analysis of molecular association studies. Stat Med. 2005;24(9):1291–306.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Acknowledgement is made to National Natural Science Foundation of China (30970761).

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Cancer Center, Research Institute of Surgery and Daping Hospital, Third Military Medical University, No.10 Changjiang Zhilu, Yuzhong District, Chongqing, 400042, China

    Jin-lu Shan, Nan Dai, Xue-qin Yang, Cheng-yuan Qian, Zhen-zhou Yang, Feng Jin, Mengxia Li & Dong Wang

Authors
  1. Jin-lu Shan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nan Dai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xue-qin Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cheng-yuan Qian
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhen-zhou Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Feng Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mengxia Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Dong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dong Wang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shan, Jl., Dai, N., Yang, Xq. et al. FokI polymorphism in vitamin D receptor gene and risk of breast cancer among Caucasian women. Tumor Biol. 35, 3503–3508 (2014). https://doi.org/10.1007/s13277-013-1462-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-1462-z

Keywords

Search

Navigation